No abstract available
Keywords:
brain; disease; glutamate; ionotropic; metabotropic.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. SF is a Distinguished Research Chair in Neurodegeneration. KA-E is a Michael Smith Health Research BC funded Health-Professional Investigator. SF is supported by Canadian Institutes for Health Research (CIHR) grants (PJT-148656 and PJT-165967) and KA-E is supported by a New Investigator grant from the Alzheimer’s Society of Canada.